Tanner Woolf, PA
Physician Assistant · Boise, IDNPI 1346994001
Payments from drug & device makers
Across 140 payments — averaging $20.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Takeda Pharmaceuticals U.S.A., Inc.$319
- Madrigal Pharmaceuticals$319
- Sanofi$272
- Regeneron Healthcare Solutions, Inc.$195
- Olympus America Inc.$89
- plus $605 from 16 others
What the payments were for
- Food & beverage$2,79399%
- Education$361%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 53 | $1,030 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $319 |
| Madrigal Pharmaceuticals | 14 | $319 |
| Sanofi | 12 | $272 |
| Regeneron Healthcare Solutions, Inc. | 11 | $195 |
| Olympus America Inc. | 1 | $89 |
| Intercept Pharmaceuticals, Inc. | 4 | $85 |
| Bristol Myers Squibb | 5 | $80 |
| Pfizer | 5 | $78 |
| Celltrion USA Inc. | 3 | $58 |
| Braintree Laboratories, Inc. | 3 | $51 |
| Aimmune Therapeutics, Inc. | 2 | $42 |
| Lucid Diagnostics Inc. | 2 | $35 |
| Gilead | 2 | $31 |
| W. L. Gore & Associates, Inc. | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Ardelyx, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| QOL Medical, LLC | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
| Digestive Care, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Skyrizi$224
How this compares
$2,829 in reported general payments places this provider in the 85th percentile of 1,027 physician assistant providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine | 27 | $8,037 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 36 | $2,143 |
| Colestipol Hcl | 18 | $625 |
| Omeprazole | 40 | $587 |
| Pantoprazole Sodium | 28 | $402 |
| Famotidine | 16 | $144 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Boise
- Benjamin KernsBoise$100K
- Autumn HeumanBoise$28K
- Stuart ColdsnowBoise$8K
- Jeffrey SmithBoise$8K
- Stephanie RitariBoise$8K
- Michael LaneBoise$7K
- Daniel LeflerBoise$7K
- David KasamisBoise$6K
- Jessica SzwecBoise$6K
- Jaclyn GolusBoise$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.